Tenax International S.p.A. engages in the designing and production of low-voltage electric road sweepers and street washers in Italy and internationally. The company provides manual street sweepers, electric urban vacuum…
Industry Peers
Auto Manufacturers| Headline | Source | Time |
|---|---|---|
Older | ||
 Tenax Therapeutics’ stock crashes on Phase III trial failure Despite the miss, a subgroup of patients with more severe disease showed more meaningful benefit - data Tenax plans to submit to the FDA and EMA. | ||
 Tenax LEVEL Trial Misses Primary Goal, but Subgroup Data Bolsters Levosimendan Case Tenax Therapeutics (NASDAQ:TENX) reported that its Phase III LEVEL trial of oral levosimendan in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction, or PH-HFpEF, did not meet its primary endpoint, though the company said subgroup, biomarker and hemody | ||
 Tenax Therapeutics Phase 3 LEVEL Trial Misses Primary Endpoint for TNX-103 The pivotal study failed to show a statistically significant improvement in exercise capacity or its key secondary symptom endpoint, although prespecified subgroup and biomarker findings are prompting Tenax to pursue a revised registrational strategy with the FDA. Key Investor TakeawaysTenax Therapeutics (NASDAQ:TENX) said its Phase 3 LEVEL trial of TNX-103 did not meet the primary 6-minute walk distance endpoint or the key secondary KCCQ symptom endpoint. | ||
 Tenax, Sionna Shares Sink After Trial Failures Shares of Tenax Therapeutics and Sionna Therapeutics tumbled Monday after the biotechs revealed separate late-stage trial failures. Tenax stock fell nearly 90% after a Phase 3 trial of its experimental heart-failure pill failed to help patients walk farther than those on a placebo. | ||
 Why Did TENX Stock Crash 89% Today? The biotech firm’s experimental drug TNX-103 failed to meet the main goal of a late-stage study in patients with pulmonary hypertension associated with heart failure with preserved ejection fraction. | ||
Tenax, Sionna plunge; MarineMax jumps premarket on reported buyout Investing.com - U.S. stock index futures edged higher on Monday, while Dow futures were little changed, as investors scaled back hopes for a breakthrough in the Middle East and looked ahead to key inflation data due later this week for fresh clues on the Federal Reserve’s interest rate path. | ||
 DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls DraftKings, Eli Lilly downgraded: Wall Street's top analyst calls | TThe Fly | |
 Tenax Therapeutics Shares Phase III Levosimendan Progress, H2 Data Timeline at Guggenheim Conference Executives from Tenax Therapeutics (NASDAQ:TENX) outlined progress on the company’s Phase III development program for levosimendan in pulmonary hypertension associated with heart failure with preserved ejection fraction (PH-HFpEF) during a fireside chat at Guggenheim’s Emerging Outlook Biotech Confe | ||
 Guggenheim Doubles Tenax (TENX) PT, Names Stock Top Pick Tenax Therapeutics Inc (NASDAQ:TENX) is one of the best performing micro cap stocks in 2025. On December 17, Guggenheim raised its price target on Tenax Therapeutics Inc (NASDAQ:TENX) to $25 from $14 and maintained a Buy rating. The firm stated that its decision to nearly double the price target for Tenax relies on a specific […] | IInsider Monkey | |